Exercise, Nutrition, and Palliative Care in Advanced Lung Cancer (ENPAL)
ENPAL
The Feasibility of an Exercise and Nutrition Supportive Care (Palliative) Intervention for Advanced Non-small-cell Lung Cancer
1 other identifier
interventional
10
1 country
1
Brief Summary
Background: Evidence supports exercise and nutrition as beneficial for enhancing QOL in earlier stages of lung cancer; however, there is minimal research of either intervention - and none with combined interventions - in advanced lung cancer patients. In addition to a multimodal intervention approach that includes nutrition and exercise, consideration of advanced cancer care symptom management is crucial for optimizing the potential benefits of either intervention. Objectives: Primary outcome measure of this study is feasibility, including recruitment (% who participate from those eligible), attendance (weekly group class), assessment completion, safety (adverse event reporting), attrition rates, and qualitative themes generated from one-on-one participant interviews. The secondary outcome to be measured is the impact of the intervention on PROs, including QOL, fatigue and symptom burden, as well as self-reported physical activity levels and physical function assessed in-person. Methods: The proposed exercise intervention will include a centre-based group exercise program plus home-based exercises, and behaviour change support for advanced non-small cell lung cancer (NSCLC) patients, classified as stage III or IV with self-reported symptom burden. Eligible participants must be cleared by the health care professionals (HCP) to engage in mild to moderate levels of physical activity (PA). Using a prospective, mixed-methods design (supported by the Medical Research Council guidance for the evaluation of complex interventions), the quantitative component of this pilot study will measure feasibility and exploratory outcome measures, with an embedded qualitative component to examine participant perspectives about study tolerability/feasibility of the intervention. A subset of participants and instructors will be recruited for qualitative interviews using purposive sampling to achieve maximum variation based on factors that may lead to different viewpoints (e.g., age, gender, lung cancer type/stage, treatment). Relevance: The proposed work will inform the design of a future pragmatic trial for this population. The goal is to build a patient-focused model of care that delivers wellness resources for advanced lung cancer care that will ultimately improve the patients' health and QOL. This approach is novel, patient-focused, and will build a tailored approach within existing resources to deliver optimal care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 11, 2020
CompletedFirst Posted
Study publicly available on registry
October 5, 2020
CompletedDecember 3, 2020
September 1, 2020
8 months
September 11, 2020
December 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Feasibility of recruitment: Percentage of those who participate from eligible patients approached
Percentage of those who participate from eligible patients approached
From 3 months pre-intervention to intervention start (week 0)
Feasibility of attendance: Percentage of classes attended from those offered to participants
Percentage of classes attended from those offered to participants
0-12 weeks
Feasibility of assessment: Percentage of possible assessments that could be completed as planned
Percentage of possible assessments that could be completed as planned
At 0 weeks (baseline)
Feasibility of assessment: Percentage of possible assessments that could be completed as planned
Percentage of possible assessments that could be completed as planned
At 12 weeks (post-intervention)
Safety of intervention
Record of any adverse events related to the intervention
0-12 weeks
Attrition Rate
Number of participants who consent but do not complete the intervention
0-12 weeks
Qualitative Feasibility: semi-structured one-on-one interviews
Participant perception of intervention feasibility via semi-structured one-on-one interviews (qualitative data, not reported on a scale)
Conducted between week 12-14
Secondary Outcomes (8)
Change in Physical Activity
Change from baseline Physical Activity at 12 weeks (2 related measurements: directly before and after intervention)
Change in Symptom Burden
Change from baseline symptom burden at 12 weeks (2 related measurements: directly before and after intervention)
Change in Lung Cancer Quality of Life
Change from baseline quality of life at 12 weeks (2 related measurements: directly before and after intervention)
Change in Fatigue
Change from baseline fatigue at 12 weeks (2 related measurements: directly before and after intervention)
Acute Symptom Burden
0-12 weeks (throughout intervention)
- +3 more secondary outcomes
Study Arms (1)
Intervention
EXPERIMENTALThe intervention arm will receive a 12-week multimodal intervention featuring exercise, nutrition, and palliative symptom management.
Interventions
1. Exercise: The exercise intervention is a 12-week group-based program, with 1 weekly 75 minute session focused on strength, balance, flexibility and aerobic capacity. 2. Palliative Symptom Management: Palliative symptom management will focus on symptoms that contribute to reduced QOL, limit ability to engage in exercise, or present barriers to oral intake. 3. Nutrition: A Registered Dietitian (RD) team will provide feedback and tailored nutrition advice based on a pre-study food recall evaluation, recommending interventions based on the nutrition assessment feedback form, such as oral nutritional supplementation or target daily protein and caloric intake.
Eligibility Criteria
You may qualify if:
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
- Hemoglobin level of ≥80g/L as measured within 30 days of enrollment
- Life expectancy \>6 months (as judged by most responsible physician)
You may not qualify if:
- Active infections at the time of enrollment
- Enteral tube feeding/parenteral nutrition
- Mechanical of functional bowel obstruction due to any cause
- Cognitive impairment
- Non-English speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Calgarylead
- Tom Baker Cancer Centrecollaborator
Study Sites (1)
Faculty of Kinesiology University of Calgary
Calgary, Alberta, T2N 1N4, Canada
Related Publications (1)
Ester M, Culos-Reed SN, Abdul-Razzak A, Daun JT, Duchek D, Francis G, Bebb G, Black J, Arlain A, Gillis C, Galloway L, Capozzi LC. Feasibility of a multimodal exercise, nutrition, and palliative care intervention in advanced lung cancer. BMC Cancer. 2021 Feb 13;21(1):159. doi: 10.1186/s12885-021-07872-y.
PMID: 33581739DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicole Culos-Reed, PhD
University of Calgary
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 11, 2020
First Posted
October 5, 2020
Study Start
September 1, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
December 3, 2020
Record last verified: 2020-09